Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status.

Aldoss I, Pham A, Li SM, Gendzekhadze K, Afkhami M, Telatar M, Hong H, Padeganeh A, Bedell V, Cao T, Khaled SK, Malki MMA, Salhotra A, Ali H, Aribi A, Palmer J, Aoun P, Spielberger R, Stein AS, Snyder D, O'Donnell MR, Murata-Collins J, Senitzer D, Weisenburger D, Forman SJ, Pullarkat V, Marcucci G, Pillai R, Nakamura R.

Haematologica. 2017 Dec;102(12):2030-2038. doi: 10.3324/haematol.2017.172544. Epub 2017 Sep 29.

2.

Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.

Riou R, Bressollette-Bodin C, Boutoille D, Gagne K, Rodallec A, Lefebvre M, Raffi F, Senitzer D, Imbert-Marcille BM, Retière C.

J Virol. 2017 Feb 14;91(5). pii: e02245-16. doi: 10.1128/JVI.02245-16. Print 2017 Mar 1.

3.

Impact of Graft-Versus-Graft Natural Killer Cell Alloreactivity on Single Unit Dominance After Double Umbilical Cord Blood Transplantation.

Rettman P, Willem C, Volteau C, Legrand N, Chevallier P, Lodé L, Esbelin J, Cesbron A, Bonneville M, Moreau P, Senitzer D, Retière C, Gagne K.

Transplantation. 2017 Sep;101(9):2092-2101. doi: 10.1097/TP.0000000000001545.

PMID:
27798515
4.

Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI).

Rettman P, Malard F, Legrand N, Avinens O, Eliaou JF, Picard C, Dormoy A, Lafarge X, de Matteis M, Kennel A, Loiseau P, Devys A, Boudifa A, Absi L, Fort M, Masson D, Quainon F, Theodorou I, Batho A, Parissiadis A, Delbos F, Drouet M, Senitzer D, Marry E, Raus N, Yakoub-Agha I, Cesbron A, Retière C, Gagne K.

Bone Marrow Transplant. 2016 Nov;51(11):1499-1503. doi: 10.1038/bmt.2016.151. Epub 2016 Jun 6. No abstract available.

PMID:
27272444
5.

New insights on the natural killer cell repertoire from a thorough analysis of cord blood cells.

Rettman P, Willem C, David G, Riou R, Legrand N, Esbelin J, Cesbron A, Senitzer D, Gagne K, Retière C.

J Leukoc Biol. 2016 Sep;100(3):471-9. doi: 10.1189/jlb.1HI0116-036R. Epub 2016 Apr 11.

PMID:
27067451
6.

Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.

Khaled SK, Palmer JM, Herzog J, Stiller T, Tsai NC, Senitzer D, Liu X, Thomas SH, Shayani S, Weitzel J, Forman SJ, Nakamura R.

Biol Blood Marrow Transplant. 2016 Feb;22(2):268-276. doi: 10.1016/j.bbmt.2015.08.027. Epub 2015 Aug 30.

7.

Use of killer cell immunoglobulin-like receptor genes as early markers of hematopoietic chimerism after double-umbilical cord blood transplantation.

Rettman P, Legrand N, Willem C, Lodé L, Chevallier P, Cesbron A, Senitzer D, Retière C, Gagne K.

Haematologica. 2015 Nov;100(11):e475-9. doi: 10.3324/haematol.2015.127993. Epub 2015 Jul 23. No abstract available.

8.

KIR2DS5 in the presence of HLA-C C2 protects against endometriosis.

Nowak I, Płoski R, Barcz E, Dziunycz P, Kamiński P, Kostrzewa G, Milewski Ł, Roszkowski PI, Senitzer D, Malejczyk J, Kuśnierczyk P.

Immunogenetics. 2015 Apr;67(4):203-9. doi: 10.1007/s00251-015-0828-3. Epub 2015 Mar 1.

9.

Analysis of graft survival in a trial of stem cell transplant in ALS.

Tadesse T, Gearing M, Senitzer D, Saxe D, Brat DJ, Bray R, Gebel H, Hill C, Boulis N, Riley J, Feldman E, Johe K, Hazel T, Polak M, Bordeau J, Federici T, Glass JD.

Ann Clin Transl Neurol. 2014 Nov;1(11):900-8. doi: 10.1002/acn3.134. Epub 2014 Oct 22.

10.

Are KIR and HLA class I genes associated with schizophrenia?

Wiśniewski A, Frydecka D, Nowak I, Majorczyk E, Senitzer D, Piotrowski P, Beszlej A, Kiejna A, Kuśnierczyk P.

Tissue Antigens. 2014 Nov;84(5):503-4. doi: 10.1111/tan.12423. Epub 2014 Sep 11. No abstract available.

PMID:
25209239
11.

Two new cases of KIR3DP1, KIR2DL4-negative genotypes, one of which is also lacking KIR3DL2.

Niepiekło-Miniewska W, Zuk N, Dubis J, Kurpisz M, Senitzer D, Havrylyuk A, Grendziak R, Witkiewicz W, Chopyak V, Kuśnierczyk P.

Arch Immunol Ther Exp (Warsz). 2014 Oct;62(5):423-9. doi: 10.1007/s00005-014-0299-5. Epub 2014 Jul 18.

12.

Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1.

Fleischhauer K, Fernandez-Viña MA, Wang T, Haagenson M, Battiwalla M, Baxter-Lowe LA, Ciceri F, Dehn J, Gajewski J, Hale GA, Heemskerk MB, Marino SR, McCarthy PL, Miklos D, Oudshoorn M, Pollack MS, Reddy V, Senitzer D, Shaw BE, Waller EK, Lee SJ, Spellman SR.

Bone Marrow Transplant. 2014 Sep;49(9):1176-83. doi: 10.1038/bmt.2014.122. Epub 2014 Jun 23.

13.

Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients.

Nakamura R, La Rosa C, Tsai W, Lacey SF, Srivastava T, Seidel A, Senitzer D, Forman SJ, Diamond DJ.

Transpl Immunol. 2014 May;30(4):128-35. doi: 10.1016/j.trim.2014.02.001. Epub 2014 Feb 26.

PMID:
24582729
14.

Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation.

Armenian SH, Ding Y, Mills G, Sun C, Venkataraman K, Wong FL, Neuhausen SL, Senitzer D, Wang S, Forman SJ, Bhatia S.

Br J Haematol. 2013 Oct;163(2):205-13. doi: 10.1111/bjh.12516. Epub 2013 Aug 8.

15.

Protective effect of the KIR2DS1 gene in atopic dermatitis.

Niepiekło-Miniewska W, Majorczyk E, Matusiak L, Gendzekhadze K, Nowak I, Narbutt J, Lesiak A, Kuna P, Ponińska J, Pietkiewicz-Sworowska A, Samoliński B, Płoski R, Szepietowski JC, Senitzer D, Kuśnierczyk P.

Gene. 2013 Sep 25;527(2):594-600. doi: 10.1016/j.gene.2013.06.015. Epub 2013 Jul 4.

PMID:
23831511
16.

Chimerism testing by quantitative PCR using Indel markers.

Gendzekhadze K, Gaidulis L, Senitzer D.

Methods Mol Biol. 2013;1034:221-37. doi: 10.1007/978-1-62703-493-7_11.

PMID:
23775739
17.

Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation.

Morishima Y, Kawase T, Malkki M, Morishima S, Spellman S, Kashiwase K, Kato S, Cesbron A, Tiercy JM, Senitzer D, Velardi A, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1197-203. doi: 10.1016/j.bbmt.2013.05.020. Epub 2013 Jun 6.

18.

Common and well-documented HLA alleles: 2012 update to the CWD catalogue.

Mack SJ, Cano P, Hollenbach JA, He J, Hurley CK, Middleton D, Moraes ME, Pereira SE, Kempenich JH, Reed EF, Setterholm M, Smith AG, Tilanus MG, Torres M, Varney MD, Voorter CE, Fischer GF, Fleischhauer K, Goodridge D, Klitz W, Little AM, Maiers M, Marsh SG, Müller CR, Noreen H, Rozemuller EH, Sanchez-Mazas A, Senitzer D, Trachtenberg E, Fernandez-Vina M.

Tissue Antigens. 2013 Apr;81(4):194-203. doi: 10.1111/tan.12093.

19.

Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma.

Israyelyan A, La Rosa C, Tsai W, Kaltcheva T, Srivastava T, Aquino L, Li J, Kim Y, Palmer J, Streja L, Senitzer D, Zaia JA, Rosenwald A, Forman SJ, Nakamura R, Diamond DJ.

Leuk Lymphoma. 2013 Nov;54(11):2490-9. doi: 10.3109/10428194.2013.783910. Epub 2013 Apr 30.

20.

Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK-cell repertoire in the French population.

Gagne K, Willem C, Legrand N, Djaoud Z, David G, Rettman P, Bressollette-Bodin C, Senitzer D, Esbelin J, Cesbron-Gautier A, Schneider T, Retière C.

Eur J Immunol. 2013 Apr;43(4):1085-98. doi: 10.1002/eji.201243007. Epub 2013 Mar 4.

21.

Hematopoietic cell transplantation with cord blood for cure of HIV infections.

Petz LD, Redei I, Bryson Y, Regan D, Kurtzberg J, Shpall E, Gutman J, Querol S, Clark P, Tonai R, Santos S, Bravo A, Spellman S, Gragert L, Rossi J, Li S, Li H, Senitzer D, Zaia J, Rosenthal J, Forman S, Chow R.

Biol Blood Marrow Transplant. 2013 Mar;19(3):393-7. doi: 10.1016/j.bbmt.2012.10.017. Epub 2012 Oct 23.

22.

Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation.

Nowak I, Magott-Procelewska M, Kowal A, Miazga M, Wagner M, Niepiekło-Miniewska W, Kamińska M, Wiśniewski A, Majorczyk E, Klinger M, Łuszczek W, Pawlik A, Płoski R, Barcz E, Senitzer D, Kuśnierczyk P.

PLoS One. 2012;7(9):e44718. doi: 10.1371/journal.pone.0044718. Epub 2012 Sep 13.

23.

A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant.

Khaled SK, Palmer J, Stiller T, Senitzer D, Maegawa R, Rodriguez R, Parker PM, Nademanee A, Cai JL, Snyder DS, Karanes C, Osorio E, Thomas SH, Forman SJ, Nakamura R.

Bone Marrow Transplant. 2013 Feb;48(2):278-83. doi: 10.1038/bmt.2012.175. Epub 2012 Sep 24.

24.

KIR2DS2 and KIR2DS4 promoter hypomethylation patterns in patients undergoing hematopoietic cell transplantation (HCT).

Gallez-Hawkins GM, Li X, Franck AE, Gendzekhadze K, Nakamura R, Forman SJ, Senitzer D, Zaia JA.

Hum Immunol. 2012 Nov;73(11):1109-15. doi: 10.1016/j.humimm.2012.08.013. Epub 2012 Aug 30.

25.

Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis.

Nakamura R, Palmer JM, O'Donnell MR, Stiller T, Thomas SH, Chao J, Alvarnas J, Parker PM, Pullarkat V, Maegawa R, Stein AS, Snyder DS, Bhatia R, Chang K, Wang S, Cai JL, Senitzer D, Forman SJ.

Leuk Res. 2012 Sep;36(9):1152-6. doi: 10.1016/j.leukres.2012.04.022. Epub 2012 Jun 5.

26.

Distinct distribution of killer-cell immunoglobulin-like receptor genes in the Mugil and Ilaita areas of Papua New Guinea.

John E, Christiansen FT, Mueller I, Schofield L, Senitzer D, Siba P, Witt CS.

Tissue Antigens. 2012 Apr;79(4):263-71. doi: 10.1111/j.1399-0039.2012.01848.x. Epub 2012 Feb 9.

PMID:
22320834
27.

Genetic variations in loci relevant to natural killer cell function are affected by ethnicity but are generally not correlated with susceptibility to HIV-1.

Aghafar MZ, Witt C, Kamarulzaman A, Ismail R, Lederman MM, Rodriguez B, Senitzer D, Lee S, Price P.

Tissue Antigens. 2012 May;79(5):367-71. doi: 10.1111/j.1399-0039.2012.01843.x. Epub 2012 Feb 2.

PMID:
22296096
28.

Can immune-related genotypes illuminate the immunopathogenesis of cytomegalovirus disease in human immunodeficiency virus-infected patients?

Affandi JS, Aghafar ZK, Rodriguez B, Lederman MM, Burrows S, Senitzer D, Price P.

Hum Immunol. 2012 Feb;73(2):168-74. doi: 10.1016/j.humimm.2011.11.005. Epub 2011 Dec 2.

PMID:
22154842
29.

Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control.

Zain J, Palmer JM, Delioukina M, Thomas S, Tsai NC, Nademanee A, Popplewell L, Gaal K, Senitzer D, Kogut N, O'Donnell M, Forman SJ.

Leuk Lymphoma. 2011 Aug;52(8):1463-73. doi: 10.3109/10428194.2011.574754. Epub 2011 Jun 24.

30.

Lack of KIR2DL4 gene in a fertile Caucasian woman.

Nowak I, Majorczyk E, Płoski R, Senitzer D, Sun JY, Kuśnierczyk P.

Tissue Antigens. 2011 Aug;78(2):115-9. doi: 10.1111/j.1399-0039.2011.01711.x. Epub 2011 May 29.

PMID:
21623736
31.

Expression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infection.

Gallez-Hawkins GM, Franck AE, Li X, Thao L, Oki A, Gendzekhadze K, Dagis A, Palmer J, Nakamura R, Forman SJ, Senitzer D, Zaia JA.

Biol Blood Marrow Transplant. 2011 Nov;17(11):1662-72. doi: 10.1016/j.bbmt.2011.04.008. Epub 2011 Apr 29.

32.

HLA-C C1C2 heterozygosity may protect women bearing the killer immunoglobulin-like receptor AA genotype from spontaneous abortion.

Nowak I, Malinowski A, Tchórzewski H, Barcz E, Wilczyński JR, Banasik M, Gryboś M, Kurpisz M, Luszczek W, Majorczyk E, Wiśniewski A, Senitzer D, Sun JY, Kuśnierczyk P.

J Reprod Immunol. 2011 Jan;88(1):32-7. doi: 10.1016/j.jri.2010.11.001. Epub 2010 Dec 4.

PMID:
21134695
33.

Does the KIR2DS5 gene protect from some human diseases?

Nowak I, Majorczyk E, Wiśniewski A, Pawlik A, Magott-Procelewska M, Passowicz-Muszyńska E, Malejczyk J, Płoski R, Giebel S, Barcz E, Zoń-Giebel A, Malinowski A, Tchórzewski H, Chlebicki A, Łuszczek W, Kurpisz M, Gryboś M, Wilczyński J, Wiland P, Senitzer D, Sun JY, Jankowska R, Klinger M, Kuśnierczyk P.

PLoS One. 2010 Aug 26;5(8):e12381. doi: 10.1371/journal.pone.0012381.

34.

One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.

Valcárcel D, Sierra J, Wang T, Kan F, Gupta V, Hale GA, Marks DI, McCarthy PL, Oudshoorn M, Petersdorf EW, Ringdén O, Setterholm M, Spellman SR, Waller EK, Gajewski JL, Marino SR, Senitzer D, Lee SJ.

Biol Blood Marrow Transplant. 2011 May;17(5):640-8. doi: 10.1016/j.bbmt.2010.07.022. Epub 2010 Jul 30.

35.

The novel HLA-B*15:180 allele appears to be a recombinant B*08/B*15 allele.

Gendzekhadze K, Goto RM, Gaidulis L, Miller MM, Senitzer D.

Tissue Antigens. 2010 Oct;76(4):334-5. doi: 10.1111/j.1399-0039.2010.01513.x.

PMID:
20579314
36.

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

Talledo M, López G, Huyghe JR, Verdonck K, González E, Clark D, Senitzer D, Vanham G, Gotuzzo E, Van Camp G, Van Laer L.

Hum Immunol. 2010 Aug;71(8):804-8. doi: 10.1016/j.humimm.2010.05.011. Epub 2010 May 17.

PMID:
20483367
37.

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.

Rodriguez R, Nakamura R, Palmer JM, Parker P, Shayani S, Nademanee A, Snyder D, Pullarkat V, Kogut N, Rosenthal J, Smith E, Karanes C, O'Donnell M, Krishnan AY, Senitzer D, Forman SJ.

Blood. 2010 Feb 4;115(5):1098-105. doi: 10.1182/blood-2009-03-207563. Epub 2009 Nov 19. Erratum in: Blood. 2010 May 27;115(21):4318.

38.

Rapid, flow cytometric assay for NK alloreactivity reveals exceptions to rules governing alloreactivity.

De Santis D, Foley BA, John E, Senitzer D, Christiansen FT, Witt CS.

Biol Blood Marrow Transplant. 2010 Feb;16(2):179-91. doi: 10.1016/j.bbmt.2009.10.026. Epub 2009 Oct 30.

39.

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

Nowak I, Malinowski A, Tchorzewski H, Barcz E, Wilczynski JR, Grybos M, Kurpisz M, Luszczek W, Banasik M, Reszczynska-Slezak D, Majorczyk E, Wisniewski A, Senitzer D, Yao Sun J, Kusnierczyk P.

J Appl Genet. 2009;50(4):391-8.

PMID:
19875891
40.

Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia.

Stein AS, Palmer JM, O'Donnell MR, Kogut NM, Spielberger RT, Slovak ML, Tsai NC, Senitzer D, Snyder DS, Thomas SH, Forman SJ.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1407-14. doi: 10.1016/j.bbmt.2009.07.003.

41.

Incidence of humoral sensitization in HLA partially mismatched hematopoietic stem cell transplantation.

Leffell MS, Cao K, Coppage M, Hansen JA, Hart JM, Pereira N, Pereira S, Reinsmoen NL, Senitzer D, Smith A, Torres M, Vega R, Fuchs E.

Tissue Antigens. 2009 Dec;74(6):494-8. doi: 10.1111/j.1399-0039.2009.01377.x. Epub 2009 Oct 4.

42.

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, Sun JY, Senitzer D, Celius EG, Thorsby E, Spurkland A, Lie BA, Harbo HF.

Ann Neurol. 2009 Jun;65(6):658-66. doi: 10.1002/ana.21695.

PMID:
19630074
43.

Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD.

Rodriguez R, Nademanee A, Palmer JM, Parker P, Nakamura R, Snyder D, Pullarkat V, Zain J, Smith E, Sahebi F, Patane K, Senitzer D, Chang K, Forman SJ.

Bone Marrow Transplant. 2010 Jan;45(1):205-7. doi: 10.1038/bmt.2009.112. Epub 2009 Jun 8. No abstract available.

PMID:
19503110
44.

The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation.

Zaia JA, Sun JY, Gallez-Hawkins GM, Thao L, Oki A, Lacey SF, Dagis A, Palmer J, Diamond DJ, Forman SJ, Senitzer D.

Biol Blood Marrow Transplant. 2009 Mar;15(3):315-25. doi: 10.1016/j.bbmt.2008.11.030.

45.

Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis.

Harvey D, Pointon JJ, Sleator C, Meenagh A, Farrar C, Sun JY, Senitzer D, Middleton D, Brown MA, Wordsworth BP.

Ann Rheum Dis. 2009 Apr;68(4):595-8. doi: 10.1136/ard.2008.095927. Epub 2008 Nov 19.

PMID:
19019897
46.

Alleles and intron polymorphism of KIR3DL1 shown by combination of allele group-specific primers and sequencing.

Sun JY, Oki A, Senitzer D.

Tissue Antigens. 2008 Dec;72(6):578-80. doi: 10.1111/j.1399-0039.2008.01141.x. Epub 2008 Sep 29.

PMID:
19000148
47.

A novel HLA-B allele, B*4093, sharing sequences with B*4006 and B*0702 in an Asian Indian donor.

Aggarwal R, Stamm L, Zhao W, Fernandez-Vina M, Senitzer D, Berka N.

Tissue Antigens. 2008 Nov;72(5):492-4. doi: 10.1111/j.1399-0039.2008.01131.x.

PMID:
18937794
48.

Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT.

Toor A, Rodriguez T, Bauml M, Mathews H, Shanti S, Senitzer D, Kini A, Norton J, Parthasarathy M, Mohideen N, Petrowsky C, Bonilla B, Smith S, Stiff P.

Bone Marrow Transplant. 2008 Dec;42(11):723-31. doi: 10.1038/bmt.2008.244. Epub 2008 Aug 18.

PMID:
18711352
49.

Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates.

Nakamura R, Auayporn N, Smith DD, Palmer J, Sun JY, Schriber J, Pullarkat V, Parker P, Rodriguez R, Stein A, Rosenthal J, Wang S, Karanas C, Gaal K, Senitzer D, Forman SJ.

Biol Blood Marrow Transplant. 2008 Apr;14(4):449-57. doi: 10.1016/j.bbmt.2008.02.005.

50.

Common and well-documented HLA alleles: report of the Ad-Hoc committee of the american society for histocompatiblity and immunogenetics.

Cano P, Klitz W, Mack SJ, Maiers M, Marsh SG, Noreen H, Reed EF, Senitzer D, Setterholm M, Smith A, Fernández-Viña M.

Hum Immunol. 2007 May;68(5):392-417. Epub 2007 Feb 15.

PMID:
17462507

Supplemental Content

Loading ...
Support Center